Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid plus phenylephrine versus phenylephrine in FESS for chronic rhinosinusitis
IRCT201212139014N15Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic rhinosinusitis (CRS) comparing Local tranexamic acid + phenylephrine with Phenylephrine alone (2 arms). Primary endpoints: Reduction of intraoperative bleeding and Improvement of surgical field. Started Jun 2013; status: completed.
02
Drugs
tranexamic acidphenylephrine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on IRCT201212139014N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212139014N15.